Advert - Bayer - Case/0216/06/24

• Date posted
  13 March 2026
• Sanction
  Advertisement,
• Case number/s
  CASE/0216/06/24 - Roche v Bayer

For the promotion of an unlicensed medicine Eylea (aflibercept 8mg) prior to the grant of its UK marketing authorisation, during two presentations at an event in December 2023, Bayer was ruled in breach of the following clauses of the 2021 Code: 

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 3.1 - Promoting a medicine prior to the grant of its marketing authorisation

Clause 5.1 - Failing to maintain high standards